The same studies identified distinct EBV latent membrane protein 1 (LMP-1)-derived peptide variants that strongly upregulate HLA-E and are associated with potent inhibition of NKG2A+ NK cells, findings predominantly observed in EBV-associated lymphoma patients (97, 106). Here, HLA-E is linked to lymphoma.